Moderate correlation between systemic IL‐6 responses and CRP with trough concentrations of voriconazole

AIMS: Voriconazole (VCZ) exhibits wide intrapatient pharmacokinetic variability, which is disadvantageous because of its narrow therapeutic range. A considerable part of this variation remains unexplainable, despite extensive knowledge of this drug. It is hypothesized that inflammation has an impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Vreugdenhil, Bas, van der Velden, Walter J. F. M., Feuth, Ton, Kox, Matthijs, Pickkers, Peter, van de Veerdonk, Frank L., Blijlevens, Nicole M. A., Brüggemann, Roger J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089823/
https://www.ncbi.nlm.nih.gov/pubmed/29744898
http://dx.doi.org/10.1111/bcp.13627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089823/
https://www.ncbi.nlm.nih.gov/pubmed/29744898
http://dx.doi.org/10.1111/bcp.13627

Ejemplares similares